Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sue Skaros"'
Autor:
Yelena Zadvornova, Ashwin N. Ananthakrishnan, Mazen Issa, Sue Skaros, Alex Ulitsky, David G. Binion, Amar S. Naik
Publikováno v:
Journal of Parenteral and Enteral Nutrition. 35:308-316
Vitamin D deficiency is common in inflammatory bowel disease (IBD). The aim of the study was to determine the prevalence and predictors of vitamin D deficiency in an IBD cohort. It was hypothesized that vitamin D deficiency is associated with increas
Autor:
David G. Binion, Dawn B. Beaulieu, John B. Williams, Sue Skaros, Yelena Zadvornova, Mazen Issa, Anita Ward, Ashwin N. Ananthakrishnan, Kathryn Johnson, Daniel J. Stein, Josh F. Knox
Publikováno v:
Inflammatory Bowel Diseases. 16:1173-1179
Background: Infliximab is efficacious in the management of moderate to severe Crohn's disease (CD). There are limited data regarding performance of infliximab in patients who require reinitiation of maintenance dosing following previous irregular exp
Autor:
Alexandru Barboi, Mazen Issa, Yelena Zadvornova, Kathryn Johnson, David G. Binion, Sue Skaros, Safwan Jaradeh, Ashwin N. Ananthakrishnan, Mary F. Otterson
Publikováno v:
Journal of Clinical Gastroenterology. 44:272-279
Functional symptoms are common in patients with inflammatory bowel disease (IBD). The autonomic nervous system has been proposed to be involved in the pathogenesis of IBD. Autonomic dysfunction (AD) is associated with systemic manifestations and alte
Autor:
Randall S. Kuhlmann, Sue Skaros, Josh F. Knox, Mary F. Otterson, Julianne Newcomer, Lydia Rosenbaum, Jeanne Emmons, Ashwin N. Ananthakrishnan, Mazen Issa, David G. Binion, Dawn B. Beaulieu
Publikováno v:
Inflammatory Bowel Diseases. 15:25-28
Background: There is no standard approach for the medical management of Crohn's disease (CD) during pregnancy and there is limited data regarding safety and efficacy of the treatments. Budesonide (Entocort® EC, AstraZeneca) is an enteric coated loca
Autor:
Michael H. Bonner, Bashar J. Qumseya, Lilani P. Perera, Sue Skaros, Amar S. Naik, Yelena Zadvornova, Mazen Issa, David G. Binion, Ashwin N. Ananthakrishnan
Publikováno v:
Inflammatory bowel diseases. 17(1)
Background: Reactivation of latent Mycobacterium tuberculosis (TB) is a rare, yet devastating infectious complication associated with anti-tumor necrosis factor alpha (TNF-α) therapy. We evaluated the performance of the QuantiFERON TB Gold test (QFT
Autor:
Mazen Issa, Alex Ulitsky, Sue Skaros, Kathryn Johnson, David G. Binion, Amar S. Naik, Lilani P. Perera, Ashwin N. Ananthakrishnan, Kia Saeian, Yelena Zadvornova, Dawn B. Beaulieu
Publikováno v:
Inflammatory bowel diseases. 16(3)
Background: Impairment of health-related quality of life (HRQoL) is an important concern in inflammatory bowel disease (IBD; ulcerative colitis [UC], Crohn's disease [CD]). Between 2%–10% of patients with IBD have primary sclerosing cholangitis (PS
Autor:
Dawn B. Beaulieu, David G. Binion, Lydia R. Weber, Heather Brandenburg, Jeanne Emmons, Josh F. Knox, Mazen Issa, Sue Skaros
Publikováno v:
American Journal of Gastroenterology. 101:S469
Autor:
Dawn B. Beaulieu, David G. Binion, Mazen Issa, Danish Thameem, Sue Skaros, Lydia R. Weber, Heather Brandenburg, Josh F. Knox, Jeanne Emmons, Scott Corman
Publikováno v:
American Journal of Gastroenterology. 101:S470